| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(01)05412-5 |
| P698 | PubMed publication ID | 11476841 |
| P50 | author | Charis Eng | Q37385393 |
| P2093 | author name string | H Hampel | |
| H Thiele | |||
| X Zhou | |||
| R M Winter | |||
| R J Gorlin | |||
| M Parisi | |||
| R C Hennekam | |||
| P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
| Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation | Q33653132 | ||
| Further diagnostic thoughts about the Elephant Man. | Q34049090 | ||
| Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis | Q40770781 | ||
| P433 | issue | 9277 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 210-211 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes | |
| P478 | volume | 358 |
| Q35869429 | A 39-bp deletion polymorphism in PTEN in African American individuals: implications for molecular diagnostic testing |
| Q24598593 | A mosaic activating mutation in AKT1 associated with the Proteus syndrome |
| Q27009377 | Amino acids and mTORC1: from lysosomes to disease |
| Q42105791 | An Illustrative Case of Neurofibromatosis Type 1 and NF1 Microdeletion |
| Q44350476 | BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels |
| Q24302790 | Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis |
| Q35204410 | Clinical and molecular heterogeneity in brazilian patients with sotos syndrome |
| Q37992686 | Commonest overgrowth syndromes |
| Q79098518 | Constipation, polyps, or cancer? let PTEN predict your future |
| Q34579796 | Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers |
| Q37313091 | Cowden syndrome: a critical review of the clinical literature |
| Q47198022 | Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease |
| Q35172112 | Detection of clinically relevant exonic copy-number changes by array CGH. |
| Q36518788 | Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies |
| Q85121775 | Epidermal Nevi |
| Q37262088 | Excision of a large abdominal wall lipoma improved bowel passage in a Proteus syndrome patient |
| Q46578462 | Feedback regulation of RTK signaling in development. |
| Q34975154 | Frequency of germline PTEN mutations in differentiated thyroid cancer |
| Q57591191 | GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations |
| Q37270416 | Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. |
| Q36843211 | Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology |
| Q57720217 | Genetics of Pten Hamartoma Tumor Syndrome (PHTS) |
| Q35447362 | Genetics of skin appendage neoplasms and related syndromes |
| Q33905657 | Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults |
| Q42685048 | Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes |
| Q33722586 | Germline PTEN mutations are rare and highly penetrant |
| Q24532136 | Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway |
| Q47109102 | Germline TTN variants are enriched in PTEN-wildtype Bannayan-Riley-Ruvalcaba syndrome. |
| Q21202845 | Hamartomatous polyposis syndromes: a review |
| Q35868041 | Highly penetrant hereditary cancer syndromes. |
| Q57522602 | Histopathological features of Proteus syndrome |
| Q40509516 | Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors |
| Q43550414 | Intestinal bleeding from arteriovenous malformations of the small bowel in a patient with Cowden syndrome: report of a case |
| Q35610161 | Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23 |
| Q53085170 | Low-level mesodermal somatic mutation mosaicism: late-onset craniofacial and cervical spinal hyperostoses. |
| Q37636466 | Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. |
| Q37800175 | Mendelian genetics of rare—and not so rare—cancers |
| Q35903855 | Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia. |
| Q46514405 | Molecular pathogenesis of focal cortical dysplasia and hemimegalencephaly |
| Q38264216 | Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy |
| Q36716837 | More than just a bump: the hamartoma syndromes |
| Q51155217 | Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. |
| Q37181471 | Muscle hemangiomatosis presenting as a severe feature in a patient with the pten mutation: expanding the phenotype of vascular malformations in bannayan-riley-ruvalcaba syndrome |
| Q41078007 | Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes |
| Q57591227 | Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma |
| Q92179836 | Overgrowth syndromes - clinical and molecular aspects and tumour risk |
| Q57320021 | Overgrowth syndromes: is dysfunctional PI3-kinase signalling a unifying mechanism? |
| Q37032524 | PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects |
| Q34942330 | PTEN function in mammalian cell size regulation |
| Q38198345 | PTEN function: the long and the short of it. |
| Q34996547 | PTEN hamartoma tumor syndrome: an overview |
| Q34824223 | PTEN hamartoma tumor syndromes. |
| Q37977769 | PTEN in DNA damage repair |
| Q35747653 | PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers |
| Q77385856 | PTEN mutations and proteus syndrome |
| Q28203387 | PTEN: one gene, many syndromes |
| Q35203208 | PTEN: tumour suppressor, multifunctional growth regulator and more |
| Q57590810 | PTENHamartoma Tumor Syndrome |
| Q24613810 | Protean PTEN: form and function |
| Q42314963 | Proteus Syndrome with Arteriovenous Malformation |
| Q38096332 | Proteus syndrome revealing itself after the treatment of a bilateral subdural haematoma |
| Q28297663 | Proteus syndrome review: molecular, clinical, and pathologic features |
| Q48125599 | Proteus syndrome with syringohydromyelia and arachnoid cyst |
| Q55037807 | Proteus syndrome: Misdiagnosis with PTEN mutations |
| Q73337528 | Proteus syndrome: report of two cases |
| Q37993135 | Proteus syndrome: three case reports with a review of the literature |
| Q34707865 | Pten signaling in gliomas |
| Q34773159 | Rapamycin treatment for a child with germline PTEN mutation |
| Q51990523 | Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. |
| Q39871283 | Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? |
| Q35970384 | The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila |
| Q28391620 | The Role of PTEN in Tumor Angiogenesis |
| Q36554428 | The challenges of Proteus syndrome: diagnosis and management |
| Q35447328 | The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis |
| Q37270446 | The role of PTEN signaling perturbations in cancer and in targeted therapy |
| Q57741132 | Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors |
| Q38098152 | When Overgrowth Bumps Into Cancer: The PTEN-Opathies |
| Q51046620 | When overgrowth bumps into cancer: the PTEN-opathies. |
Search more.